DNA and RNA Sample Preparation Market

Global DNA and RNA Sample Preparation Market Size (2023 To 2028)

The global DNA and RNA sample preparation market is predicted to grow from USD 1.9 billion in 2023 to USD 3.29 billion by 2028, growing at a CAGR of 11.6% from 2023 to 2028.

MARKET DRIVERS:

The growing prevalence of infectious diseases worldwide primarily drives the growth of the DNA and RNA sample preparation market. The number of infectious diseases is rising worldwide. Due to the global burden of infectious disease, there is a necessity for accurate, reliable and newer detection technologies. According to a recent report by the WHO, approximately 1.6 million people died from tuberculosis. The rising prevalence of infectious diseases needs proper care and appropriate diagnostic testing directly related to the preparation of DNA and RNA samples.

The growing number of new product launches is another major factor propelling the global DNA and RNA sample preparation market. As the burden of infectious diseases rising rapidly and needs proper diagnosis and treatment, the key market players have been focusing more on receiving approval for the newer diagnostic kits. In November 2022, my lab discovery solution received CDSCO and ICMR approval for its product Pathodetect. It has launched an RT-PCR-based kit that allows automated testing of the sample within 2 hours, Many key players nowadays are launching new products that require DNA and RNA samples.

The rising demand for personalized medicine drives the growth of the DNA and RNA sample preparation market. Personalized medicine gain traction. Now many pharmaceutical companies have been increasing targeted therapies that focus on specific genetic mutations and DNA and RNA samples are vital for identifying the right patient population and monitoring treatment efficacy. Advancements in DNA and RNA sample preparation have also led to the development of non-invasive testing methods, This technique allows for the detection of genetic material from the body fluid, also the personalized medicine demand has driven increased research in genomic and molecular biology. The emerging demand for targeted therapies, the rising prevalence of genetic disorders and the increasing importance of genomics in drug discovery and development fuels the growth rate of the global DNA and RNA sample preparation market.

MARKET RESTRAINTS:

The high cost of products and low investment hampers the growth of the global DNA and RNA sample preparation market. Research in the life science sector is complex and have uncertainties in terms of result. DNA and RNA sample preparation products, such as extraction kits, reagents, and equipment, can be expensive. These expenses can pose challenges, particularly for researchers and healthcare facilities with limited budgets. The low investment in R&D can hinder the development of new and improved sample preparation solutions. The high cost of the product is a major restraining factor that acts as a barrier for healthcare facilities from adopting advanced DNA and RNA sample preparation methods.

Impact of COVID-19 on the global DNA and RNA sample preparation market:

The COVID-19 pandemic crisis has had a positive impact on the DNA and RNA sample preparation market. The sudden outbreak of the COVID-19 pandemic has raised a significant surge in demand for diagnostic testing, including RNA-based tests and polymerase chain reactions. The emerging demand for testing led to a spike in the need for DNA and RNA sample preparation products and technologies and companies got more opportunities during the COVID-19 pandemic time for provide sample preparation kits and services and favoured the DNA and RNA sample preparation market growth. The COVID-19 pandemic also shifted the focus of research institutes toward innovation in healthcare fields, which led to the influence of the demand for specific sample preparation techniques and products relevant to COVID-19 research. The mandatory social isolation and lockdown conditions have impacted the delay for certain sample preparation products and services. The detrimental impact on the economy has affected the funding and investment landscape in life science, including DNA and RNA sample preparation. Thus, the pandemic crisis has positively impacted the DNA and RNA sample preparation market and this market has faced several challenges during a pandemic. 

REPORT COVERAGE:

This research report on the DNA and RNA sample preparation market has been segmented and sub-segmented based on product, end-user, application and region.

DNA and RNA Sample Preparation Market – By Product Type:

• Workstations
• Kits 
• Reagents & Consumables

Based on product type, the kits segment is predicted to account for the leading share of the global DNA and RNA sample preparation market during the forecast period. The growing patient population suffering from infectious diseases has been fuelling the demand for proper medication and diagnostic testing and increasing demand for sample preparation kits, which is one of the key factors propelling the growth of the kits segment in the global market.

The reagents and consumables segment is another promising segment and is expected to account for a substantial share of the worldwide market during the forecast period. Reagents play a crucial role in isolating, amplifying, and purifying DNA and RNA molecules. Thus, the advancements in the genomic research field are witness to a rise in the demand for reagents in the upcoming years. DNA and RNA sample preparation reagents are important components in molecular diagnostic techniques for the detection and monitoring of various diseases. Thus, the demand for reliable and efficient reagents has surged. The rising demand for reagents for the preparation of personalized medicine, contributes to the growth rate of the reagents and consumables segment in the global market.

DNA and RNA Sample Preparation Market – By Application:

• Clinical Testing
• Diagnostic Testing
• Research Applications

Based on application, the clinical testing segment is anticipated to occupy the largest share of the worldwide market during the forecast period. The adoption of clinical testing has increased significantly in the recent past owing to the growing elderly population and the rising prevalence of chronic diseases among the world population. The rise of precision medicine initiatives and the increasing integration of genomic data into clinical decisions further boost segmental growth. Clinical testing using DNA and RNA sample preparation techniques is crucial for the diagnosis of genetic disease conditions, and drives the growth of the clinical testing segment in the global market.

The diagnostic testing segment is predicted to capture a considerable share of the worldwide market during the forecast period. The growing aging population and rising prevalence of chronic diseases drive the growth of the diagnostic testing segment in the worldwide market.

DNA and RNA Sample Preparation Market – By End-User:

• Hospitals 
• Diagnostic Centers
• Academic & Research Institutes
• Forensic Science Laboratories
• Contract Research Organizations

Based on end-user, the hospital segment is anticipated to hold the largest share of the global market during the forecast period. Hospitals play a crucial role in patient care and disease diagnosis, with the rising importance of molecular diagnostics in precision medicine and personalized treatment approaches. Hospitals also frequently encounter patients with suspected genetic conditions, The DNA and RNA sample preparation methods are essential for the diagnosis of these diseases.

The diagnostic centers segment accounted for the second largest share of the global market in 2022 and is estimated to showcase a healthy CAGR in the coming years. Diagnostic centers play a vital role in performing various medical tests, including molecular diagnostics based on DNA and RNA analysis. Diagnostic centers adopt genomic technologies and incorporate DNA and RNA sample preparation methods, The rising understanding of the genetic basis of diseases and the potential for targeted therapies drive the demand for sample preparation solutions in diagnostic centers.

DNA and RNA Sample Preparation Market – By Region:

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

North America is predicted to account for the major share of the global market during the forecast period owing to the growing patient population of chronic diseases.

The Asia-Pacific is predicted to witness the fastest CAGR during the forecast period. Factors such as rapid development in the healthcare infrastructure, the expansion of large companies, and the increasing cases of hematological diseases drive the DNA and RNA sample preparation market in the Asia-Pacific region.

Europe is predicted to account for a substantial share of the worldwide market during the forecast period. Advancements in genomic and molecular diagnostics and the rising prevalence of chronic disease propel the European market growth. The focus of the European region on research and development and the adoption of cutting-edge technologies in DNA and RNA sample preparation drive the demand for sample preparation products in various applications, including research and clinical diagnostic and personalized medicine, further fueling the growth rate of the European market.

The Latin American region is projected to hold a considerable share of the global market during the forecast period. Factors such as consistent improvements in the healthcare infrastructure, rising prevalence of infectious and chronic diseases, and expansion of biotechnology and pharmaceutical industries drive the growth of the Latin American market.

The Middle East and Africa region is expected to grow at a steady CAGR during the forecast period. The burden of genetic and infectious diseases in the MEA region drives the regional market growth.

KEY MARKET PLAYERS:

Agilent Technologies, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories Inc., DiaSorin S.p.A, F. Hoffmann-La Roche, Miroculus, Inc., Illumina, Inc., PerkinElmer, Inc., QIAGEN, Sigma Aldrich Corp., Tecan Group AG, and Thermo Fisher Scientific, Inc. are some of the notable companies in the global DNA and RNA sample preparation market.

RECENT DEVELOPMENT IN THE MARKET:

• In March 2021, Agilent Inc., a U.S.-based biotechnology company, acquired Resolution Bioscience, a U.S.-based cancer diagnostic company to strengthen its position in oncology diagnostic solutions. This combination combines Resolution Bioscience’s non-invasive liquid biopsy platform that improves cancer diagnostics with Agilent’s tissue-based companion diagnostics on the commercial and regulatory scale. This will also accelerate precision oncology testing for patients worldwide through distributed NGS-based diagnostic kits.
• In August 2022, Qiagen, a Germany-based molecular diagnostic company, launched new solutions, QIAseq targeted DNA pro panels and QIAseq UPXome RNA Library Kit, which can be used in preparing samples for determining their nucleic acid sequencing.  This can significantly accelerate DNA variant detection and RNA sequencing of low-input samples. They provide ease of use, efficiency and expanded, ultra-sensitive variant analysis using integrated unique molecular indices (UMIs). The panels are powerful tools for detecting genetic variations such as somatic mutations, single nucleotide polymorphisms, and copy number variations.
• In March 2022, Beckman Coulter Life Sciences, a U.S.-based diagnostic company, launched CellMek SPS, a fully automated sample preparation system for clinical flow cytometer. In this system, the sample can be washed, stained, and lysed without the need of manual intervention. This system offers on-demand processing for a multitude of sample types to help laboratories to expand their capabilities.